
Safety and immunogenicity of a recombinant hepatitis B vaccine manufactured by a modified process in renal pre-dialysis and dialysis patients
Keywords: تشدید پلاسمون سطحی; Hepatitis B vaccine; Safety; Immunogenicity; AEs; adverse experiences; ANOVA; analysis of variance; anti-HBs; serum antibody to HBsAg; CI; confidence interval; GMC; geometric mean concentration; HBsAg; hepatitis B surface antigen; mpHBV; modified process